Skip to Main Content

Author Details

Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
1998
93
35
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35233576Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19.bioRxiv2023
37491352Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19.Nat Commun2023
37556555Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts.Sci Transl Med2023
37352333Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters.PLoS Pathog2023
36949107Genetic sequencing of a 1944 Rocky Mountain spotted fever vaccine.Sci Rep2023
37442094Viral mimicry protects from infection when you're expecting.Cell Host Microbe2023
36697369Positive-strand RNA viruses-a Keystone Symposia report.Ann N Y Acad Sci2023
36897927Constitutive expression and distinct properties of IFN-epsilon protect the female reproductive tract from Zika virus infection.PLoS Pathog2023
35263563The domiNO effect turns macrophage activation deadly.Immunity2022
35750336MAVS Expression in Alveolar Macrophages Is Essential for Host Resistance against <i>Aspergillus fumigatus</i>.J Immunol2022
36561185Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters.bioRxiv2022
36264642Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2.J Clin Invest2022
33880473Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2.bioRxiv2022
34889942Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge.J Exp Med2022
35039442Age-related differences in immune dynamics during SARS-CoV-2 infection in rhesus macaques.Life Sci Alliance2022
35233572TARGETED DOWN REGULATION OF CORE MITOCHONDRIAL GENES DURING SARS-COV-2 INFECTION.bioRxiv2022
33431511Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys.Sci Transl Med2021
33801908From Capsids to Complexes: Expanding the Role of TRIM5α in the Restriction of Divergent RNA Viruses and Elements.Viruses2021
33831142Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses.J Exp Med2021
34855915A pigtailed macaque model of Kyasanur Forest disease virus and Alkhurma hemorrhagic disease virus pathogenesis.PLoS Pathog2021
34876520A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.Proc Natl Acad Sci U S A2021
34706234Mitophagy antagonism by ZIKV reveals Ajuba as a regulator of PINK1 signaling, PKR-dependent inflammation, and viral invasion of tissues.Cell Rep2021
34586867Genome-Wide CRISPR Screen Identifies RACK1 as a Critical Host Factor for Flavivirus Replication.J Virol2021
34522865Pulmonary infection induces persistent, pathogen-specific lipidomic changes influencing trained immunity.iScience2021
34578379Disruption of the Golgi Apparatus and Contribution of the Endoplasmic Reticulum to the SARS-CoV-2 Replication Complex.Viruses2021
34172587MyD88 signaling by neurons induces chemokines that recruit protective leukocytes to the virus-infected CNS.Sci Immunol2021
34162308The liver X receptor agonist LXR 623 restricts flavivirus replication.Emerg Microbes Infect2021
34046906Minipool testing for SARS-CoV-2 RNA in United States blood donors.Transfusion2021
32839775SARS-CoV-2 infection dynamics in lungs of African green monkeys.bioRxiv2020
32606244The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation.Proc Natl Acad Sci U S A2020
32803199K18-hACE2 mice develop respiratory disease resembling severe COVID-19.bioRxiv2020
32641828Envelope protein ubiquitination drives entry and pathogenesis of Zika virus.Nature2020
30890660Regulation of type I interferon: It's HIP to be K2.Sci Signal2019
31796542Simian Immunodeficiency Virus Infection of Rhesus Macaques Results in Delayed Zika Virus Clearance.mBio2019
31739796Neuronal maturation reduces the type I IFN response to orthobunyavirus infection and leads to increased apoptosis of human neurons.J Neuroinflammation2019
31189110TRIM5α Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation.Cell Rep2019
31129244TRAF6 Plays a Proviral Role in Tick-Borne Flavivirus Infection through Interaction with the NS3 Protease.iScience2019
28899653Role of autophagy in Zika virus infection and pathogenesis.Virus Res2018
30081931A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle.Genome Med2018
30134198Tip Your Cap for Ebola Virus Neutralization.Immunity2018
29969788Unique Francisella Phosphatidylethanolamine Acts as a Potent Anti-Inflammatory Lipid.J Innate Immun2018
29925658The Methyltransferase-Like Domain of Chikungunya Virus nsP2 Inhibits the Interferon Response by Promoting the Nuclear Export of STAT1.J Virol2018
29696134Lethal Zika Virus Disease Models in Young and Older Interferon α/β Receptor Knock Out Mice.Front Cell Infect Microbiol2018
29746837An Immunocompetent Mouse Model of Zika Virus Infection.Cell Host Microbe2018
29246952Cutting Edge: CCR2 Is Not Required for Ly6C<sup>hi</sup> Monocyte Egress from the Bone Marrow but Is Necessary for Migration within the Brain in La Crosse Virus Encephalitis.J Immunol2018
27881649The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling.J Virol2017
28111475Immunobiology of Ebola and Lassa virus infections.Nat Rev Immunol2017
28330900Adaptive Immune Responses to Zika Virus Are Important for Controlling Virus Infection and Preventing Infection in Brain and Testes.J Immunol2017
28099857A Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection.Cell Rep2017
29024636IFN-Lambda: The Key to Norovirus's Secret Hideaway.Cell Host Microbe2017
  • 1 - 50 of 93

Recommended Authors

James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 10
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2015
Number of shared co-authors 10
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 6
Mary K McCarthy
University of Colorado School of Medicine
Career Start Year 2012
Number of shared co-authors 4
Maxime Chazal
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2012
Number of shared co-authors 4
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 7
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 8
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 8
Maria Teresa S??nchez-Aparicio
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 9
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 4
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 19
Colm Atkins
Rutgers University
Career Start Year 2007
Number of shared co-authors 10
Priya Luthra
Trudeau Institute
Career Start Year 2007
Number of shared co-authors 9
Nicholas S Heaton
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 7
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 11
Courtney Wilkins
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2005
Number of shared co-authors 6
Nolwenn Jouvenet
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2003
Number of shared co-authors 5
Thomas E Morrison
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 6
Victor R DeFilippis
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 2
Larissa B Thackray
Washington University School of Medicine
Career Start Year 1996
Number of shared co-authors 8
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 19
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 20
Ana Fernandez-Sesma
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 11
Sara Cherry
University of Pennsylvania
Career Start Year 1993
Number of shared co-authors 13
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 2
Alec J Hirsch
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1992
Number of shared co-authors 3
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 5
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1988
Number of shared co-authors 21
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 6
Robert F Garry
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 4

Collaborators

Shelly J Robertson
National Institute of Allergy and Infectious Diseases
Co-authored papers 23
Kristin L McNally
National Institute of Allergy and Infectious Diseases
Co-authored papers 19
Gail L Sturdevant
National Institute of Allergy and Infectious Diseases
Co-authored papers 10
Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 8
Travis R Taylor
University of Toledo
Co-authored papers 8
Gary P Kobinger
University of Texas Medical Branch
Co-authored papers 3
Kimberly Meade-White
National Institutes of Allergy and Infectious Disease, National Institutes of Health
Co-authored papers 3
Moses Massaquoi
The Fenway Institute
Co-authored papers 3
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
James E Strong
University of Manitoba
Co-authored papers 3
Michael S Diamond
Washington University School of Medicine
Co-authored papers 2
Stephen B Baylin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Co-authored papers 2
Sarah L Anzick
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 2
Pei-Yong Shi
University of Texas Medical Branch
Co-authored papers 2
Cem Meydan
Co-authored papers 2
Jonathan Foox
Co-authored papers 2
Douglas C Wallace
Co-authored papers 2
Armand Sprecher
Section of Emergency Medicine,University of Nebraska Medical Center
Co-authored papers 2
Christoph Preuss
Universite de Montreal
Co-authored papers 2
Scott L Weiss
Sidney Kimmel Medical College at Thomas Jefferson University
Co-authored papers 2
Shashank Tripathi
Indian Institute of Science
Co-authored papers 2
Hossein Fazelinia
Co-authored papers 2
Michael G Katze
University of Washington
Co-authored papers 2
Afshin Beheshti
Co-authored papers 2
Deborah G Murdock
Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia
Co-authored papers 2
Yared H Kidane
Co-authored papers 2
Robert Meller
Co-authored papers 2
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers 2
Yuanchao Zhang
Co-authored papers 2
Jonathan C Schisler
Co-authored papers 2
Release 1.2